Avastin no es lo mismo que Lucentis y Lucentis no es lo mismo que Avastin
نویسندگان
چکیده
منابع مشابه
Ranibizumab (Lucentis) versus bevacizumab (Avastin): modelling cost effectiveness.
Two new drugs provide startling benefits in the treatment of age-related macular degeneration (AMD). The clinical and cost effectiveness of ranibizumab (Lucentis) was compared to that of bevacizumab (Avastin), which costs up to 100 times less. A cost effectiveness model was developed to assess the cost per quality adjusted life year (QALY) over 10 years. For predominantly classic AMD, the effic...
متن کاملAvastin and Lucentis: what do patients know? A prospective questionnaire survey
OBJECTIVES To assess patients' knowledge of their drug therapy for neovascular macular degeneration and to identify which aspects of the drug they considered most important if given the option of switching to an alternative drug. DESIGN Prospective questionnaire survey. SETTING Wolverhampton, England. PARTICIPANTS A total of 126 patients attending our hospital service for intravitreal ran...
متن کاملHow to treat recurrences after Avastin treatment for neovascular AMD: stick to Avastin or switch to Lucentis?
Before the recent approvement of ranibizumab (Lucentis) for the treatment of neovascular age-related macular degeneration (AMD), bevazicumab (Avastin) had been successfully used as an off-label treatment for this condition. As a consequence, in daily practice we are confronted with a large number of patients having received Avastin injections in the past, now facing a recurrence of the disease ...
متن کاملHacia la Generación Automática de Mecánicas de Juego: un Editor de Reglas para Eryna
Resumen. Este artículo es parte de un trabajo emergente dirigido a la creación automática de juegos de estrategia en tiempo real (RTS), lo cual incluye la generación de contenido, la creación de la inteligencia artificial del juego (es decir, de los jugadores virtuales) y de la propia mecánica del mismo. En este artículo se describe un editor que consta de múltiples parámetros que pueden config...
متن کاملCorneal neovascularization and the utility of topical VEGF inhibition: ranibizumab (Lucentis) vs bevacizumab (Avastin).
Corneal avascularity is necessary for the preservation of optimal vision. The cornea maintains a dynamic balance between pro- and antiangiogenic factors that allows it to remain avascular under normal homeostatic conditions; however, corneal avascularity can be compromised by pathologic conditions that negate the cornea's "angiogenic privilege." The clinical relevance of corneal neovascularizat...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Archivos de la Sociedad Española de Oftalmología
سال: 2009
ISSN: 0365-6691
DOI: 10.4321/s0365-66912009000900002